Document Detail


Carboxypeptidase G2 rescue in a 79 year-old patient with cranial lymphoma after high-dose methotrexate induced acute renal failure.
MedLine Citation:
PMID:  10609804     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
A 79 year-old female patient presented with immunoblastic B-cell lymphoma of the ethmoidal sinuses and destruction of the anterior cranial fossa. After 3 cycles of high-dose methorexate (HD-MTX) MTX serum level remained elevated and creatinine serum levels raised. The patient received Carboxypeptidase G2 (CPG2) intravenously. Within one hour the MTX serum level decreased to <1 micromol/l as determined by high pressure liquid chromatography (HPLC). The patient recovered without significant toxicity and attained a long lasting ongoing (>14 months) complete remission. In this case we were able to demonstrate that rescue from HD-MT nephrotoxicity by CPG2 is also safe and effective in patients with advanced age with impaired renal function. With the help of CPG2, sufficient and potentially curative therapy with HD-MTX may also be provided to patients with a high risk of renal failure.
Authors:
A Krackhardt; S Schwartz; A Korfel; E Thiel
Related Documents :
21257724 - Evaluation of the respective influence of thyroid hormones and thyrotropin on blood coa...
16311264 - Haemodialysis vascular access problems in canada: results from the dialysis outcomes an...
2545994 - Increased serum levels of endopeptidase 24.11 ('enkephalinase') in patients with end-st...
21530164 - A voice acoustic analysis of thyroid adenoma patients after a unilateral thyroid lobect...
1573584 - Oral hypoglycaemic agents: the first thirty years.
2788474 - Rigid endoscopy under general anaesthesia is safe for chronic injection sclerotherapy.
Publication Detail:
Type:  Case Reports; Journal Article    
Journal Detail:
Title:  Leukemia & lymphoma     Volume:  35     ISSN:  1042-8194     ISO Abbreviation:  Leuk. Lymphoma     Publication Date:  1999 Nov 
Date Detail:
Created Date:  2000-02-14     Completed Date:  2000-02-14     Revised Date:  2006-04-24    
Medline Journal Info:
Nlm Unique ID:  9007422     Medline TA:  Leuk Lymphoma     Country:  SWITZERLAND    
Other Details:
Languages:  eng     Pagination:  631-5     Citation Subset:  IM    
Affiliation:
Medizinische Klinik III, Hämatologie, Onkologie und Transfusionsmedizin, Freie Universität Berlin, Universitäsklinikum Benjamin Franklin, Germany. aljoscha@zedat.fu-berlin.de
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Aged
Antimetabolites, Antineoplastic / administration & dosage,  adverse effects*
Antineoplastic Combined Chemotherapy Protocols / therapeutic use
Bacterial Proteins / therapeutic use*
Carmustine / administration & dosage
Combined Modality Therapy
Cyclophosphamide / administration & dosage
Dexamethasone / administration & dosage
Diuretics / therapeutic use
Doxorubicin / administration & dosage
Ethmoid Sinus*
Female
Fluid Therapy
Folic Acid / metabolism
Furosemide / therapeutic use
Humans
Kidney Failure, Acute / chemically induced*,  drug therapy,  therapy
Leucovorin / administration & dosage
Lymphoma, B-Cell / drug therapy*
Lymphoma, Large-Cell, Immunoblastic / drug therapy*,  pathology
Methotrexate / administration & dosage,  adverse effects*,  antagonists & inhibitors,  metabolism
Paranasal Sinus Neoplasms / drug therapy*
Prednisone / administration & dosage
Procarbazine / administration & dosage
Remission Induction
Vincristine / administration & dosage
gamma-Glutamyl Hydrolase / therapeutic use*
Chemical
Reg. No./Substance:
0/Antimetabolites, Antineoplastic; 0/Bacterial Proteins; 0/CHOP protocol; 0/Diuretics; 154-93-8/Carmustine; 23214-92-8/Doxorubicin; 50-02-2/Dexamethasone; 50-18-0/Cyclophosphamide; 53-03-2/Prednisone; 54-31-9/Furosemide; 57-22-7/Vincristine; 58-05-9/Leucovorin; 59-05-2/Methotrexate; 59-30-3/Folic Acid; 671-16-9/Procarbazine; EC 3.4.19.9/gamma-Glutamyl Hydrolase

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Acute minimally differentiated myeloid leukemia (M0) with inv(3)(q21q26).
Next Document:  HTLV-I induced intestinal lymphoma.